More Articles

Biosimilars marketed in Europe Reports | Posted 18/05/2012

Europe was the first region to approve and introduce biosimilars into the market back in 2006, and now in 2012 the continent is the largest biosimilars market in the world, with 14 biosimilars appr...

Mexican biocomparables guidelines come into force Guidelines | Posted 18/05/2012

The Federal Commission for the Protection Against Sanitary Risks (COFEPRIS) announced on 20 April 2012 that the Mexican guidelines for biocomparables had come into force.

Generic atorvastatin could save NHS GBP 350 million a year Generics/News | Posted 18/05/2012

Generics of Pfizer’s blockbuster cholesterol treatment Lipitor (atorvastatin) could save the National Health Service (NHS) in the UK a whopping GBP 250 million or more during the coming years, foll...

IMS Health enlisted as information provider for drug shortages Pharma News | Posted 18/05/2012

The Generic Pharmaceutical Association (GPhA) announced on 19 April 2012 that it had selected IMS Health (IMS) to serve as the Independent Third Party in the Accelerated Recovery Initiative (ARI),...

Biosimilars approved and marketed in Belgium Biosimilars/General | Posted 18/05/2012

Last updated: 18 May 2012 The Federal Agency for Medicines and Health Products (FAMHP), formerly the Directorate-General for Medicinal Products of the Federal Public Service (FPS) Public Healt...

Daiichi Sankyo and Coherus BioSciences make biosimilars deal Biosimilars/News | Posted 18/05/2012

Coherus BioSciences and Daiichi Sankyo announced on 7 May 2012 that the two companies had made an exclusive agreement to develop and commercialise biosimilars of etanercept and rituximab in certain...

FDA says efforts to prevent drug shortages are working Pharma News | Posted 11/05/2012

FDA Commissioner Ms Margaret Hamburg has reported that the FDA’s office of drug shortages has made progress in preventing drug shortages and working with industry to provide advanced warning when t...

Can generic competition succeed at reducing cost of atorvastatin? Generics/Research | Posted 11/05/2012

The generic form of the cholesterol-lowering drug Lipitor (atorvastatin) has the potential for significant cost savings for payers following its introduction in November 2011. However, ‘aggressive...